POMDOCTOR LIMITED American Depositary Shares (POM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, POMDOCTOR LIMITED American Depositary Shares (POM) has a cash flow conversion efficiency ratio of 0.033x as of March 2020. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.08 Billion) by net assets ($32.48 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
POMDOCTOR LIMITED American Depositary Shares - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how POMDOCTOR LIMITED American Depositary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read POM current and long-term liabilities for a breakdown of total debt and financial obligations.
POMDOCTOR LIMITED American Depositary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of POMDOCTOR LIMITED American Depositary Shares ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lichen China Limited Class A Ordinary Shares
NASDAQ:LICN
|
-0.227x |
|
EV RESOURCES LTD.
F:R1EA
|
N/A |
|
Leaders Technology Investment Co. Ltd
KQ:019570
|
-0.061x |
|
Avillion Bhd
KLSE:8885
|
-0.004x |
|
Cosmos Exploration Ltd
AU:C1X
|
-0.171x |
|
Grand Baoxin Auto Group Limited
F:6BA
|
-0.007x |
|
Energisme
PA:ALNRG
|
-1.376x |
|
Tasman Resources Ltd
AU:TAS
|
-0.077x |
Annual Cash Flow Conversion Efficiency for POMDOCTOR LIMITED American Depositary Shares (2003–2024)
The table below shows the annual cash flow conversion efficiency of POMDOCTOR LIMITED American Depositary Shares from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see how much is POMDOCTOR LIMITED American Depositary Sh worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-2.09 Billion | $-16.13 Million | 0.008x | -67.02% |
| 2023-12-31 | $-1.96 Billion | $-45.80 Million | 0.023x | +101.27% |
| 2022-12-31 | $-1.90 Billion | $-22.02 Million | 0.012x | +31.49% |
| 2021-12-31 | $-1.78 Billion | $-15.68 Million | 0.009x | -92.16% |
| 2020-12-31 | $-309.35 Million | $-34.80 Million | 0.112x | +332.60% |
| 2019-12-31 | $3.27 Billion | $85.00 Million | 0.026x | -90.75% |
| 2018-12-31 | $30.76 Billion | $8.64 Billion | 0.281x | +12.15% |
| 2017-12-31 | $29.86 Billion | $7.48 Billion | 0.251x | -23.35% |
| 2016-12-31 | $25.84 Billion | $8.45 Billion | 0.327x | +53.61% |
| 2015-12-31 | $4.41 Billion | $939.00 Million | 0.213x | +7.69% |
| 2014-12-31 | $4.32 Billion | $854.00 Million | 0.198x | +71.55% |
| 2013-12-31 | $4.32 Billion | $497.00 Million | 0.115x | -13.50% |
| 2012-12-31 | $4.45 Billion | $592.00 Million | 0.133x | -15.84% |
| 2011-12-31 | $4.34 Billion | $686.00 Million | 0.158x | +88.51% |
| 2010-12-31 | $703.00 Million | $59.00 Million | 0.084x | +1966.11% |
| 2009-12-31 | $10.83 Billion | $44.00 Million | 0.004x | -65.59% |
| 2008-12-31 | $11.10 Billion | $131.00 Million | 0.012x | -3.54% |
| 2007-12-31 | $10.38 Billion | $127.00 Million | 0.012x | +77.75% |
| 2006-12-31 | $9.88 Billion | $68.00 Million | 0.007x | +85.86% |
| 2005-12-31 | $9.18 Billion | $34.00 Million | 0.004x | -46.21% |
| 2004-12-31 | $8.28 Billion | $57.00 Million | 0.007x | -66.55% |
| 2003-12-31 | $8.06 Billion | $166.00 Million | 0.021x | -- |
About POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company's busines… Read more